Biotech · Private company · New York, NY, US

Applied Therapeutics, Inc.

SEC CIK 0001697532

Track this companyFree. Adds Applied Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials61 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline4

AT-001Phase 3 · Diabetic CardiomyopathiesClinicalTrials.gov · fetched Nov 12, 2026
AT-007Phase 3 · Classic GalactosemiaClinicalTrials.gov · fetched Nov 12, 2026
AT-007Phase 3 · Hereditary Neuropathy Caused by SORD DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
GovorestatPhase 3 · Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD)ClinicalTrials.gov · fetched Nov 12, 2026

Confirmatory Study of Govorestat in CMT-SORDPHASE3 · WITHDRAWN · started May 1, 2026ClinicalTrials.gov NCT07191912 · fetched Nov 12, 2026
Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) DeficiencyPHASE2_PHASE3 · COMPLETED · started Jan 1, 2022ClinicalTrials.gov NCT05397665 · fetched Nov 12, 2026
AT-007 in Adult Subjects With Classic Galactosemia (CG)PHASE3 · UNKNOWN · started Oct 1, 2021ClinicalTrials.gov NCT05418829 · fetched Nov 12, 2026
Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic GalactosemiaPHASE2_PHASE3 · COMPLETED · started Mar 20, 2021ClinicalTrials.gov NCT04902781 · fetched Nov 12, 2026
Safety and Efficacy of AT-001 in Patients With Diabetic CardiomyopathyPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 20, 2019ClinicalTrials.gov NCT04083339 · fetched Nov 12, 2026
Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic GalactosemiaPHASE1_PHASE2 · COMPLETED · started Jun 21, 2019ClinicalTrials.gov NCT04117711 · fetched Nov 12, 2026